Joel Bard
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Molecular Biology top 10%
- Bacillus and Francisella bacterial research
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- Protein Structure and Dynamics
Papers in
-
- RNA Research and Splicing 2
- RNA and protein synthesis mechanisms 2
- Biochemical and Molecular Research 2
-
- Pharmacological Effects of Natural Compounds 2
- Co-authors
- Andrew Bohm (2 shared papers)Matthew H. Sazinsky (1 shared paper)Stephen J. Lippard (1 shared paper)Alberto Di Donato (1 shared paper)Shui-Zhong Yan (1 shared paper)Chester Lee Drum (1 shared paper)Sandriyana Soelaiman (1 shared paper)Zenon Grabarek (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (4 papers)Journal of Biological Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Joel Bard
17 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 98
- Hepatology 127
- Molecular Biology 779
- Inorganic Chemistry 133
- Infectious Diseases 117
- Genetics 163
Countries citing papers authored by Joel Bard
This map shows the geographic impact of Joel Bard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Bard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Bard more than expected).
Fields of papers citing papers by Joel Bard
This network shows the impact of papers produced by Joel Bard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Bard. The network helps show where Joel Bard may publish in the future.
Co-authors
The 25 scholars most cited alongside Joel Bard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 330 | |
| 2 | 2004 | 170 | |
| 3 | 2000 | 98 | |
| 4 | 2009 | 94 | |
| 5 | 2008 | 93 | |
| 6 | 2009 | 90 | |
| 7 | 2001 | 86 | |
| 8 | 2002 | 51 | |
| 9 | 2006 | 51 | |
| 10 | 2009 | 49 | |
| 11 | 2012 | 46 | |
| 12 | 2007 | 40 | |
| 13 | 2010 | 37 | |
| 14 | 2015 | 19 | |
| 15 | 2012 | 12 | |
| 16 | 2020 | 12 | |
| 17 | 2000 | 6 |
About Joel Bard
Joel Bard is a scholar working on Molecular Biology, Pharmacology, Genetics, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (2 papers), Hepatitis C virus research (2 papers), RNA Research and Splicing (2 papers), Hormonal Regulation and Hypertension (2 papers), Pharmacological Effects of Natural Compounds (2 papers), RNA and protein synthesis mechanisms (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Hepatology (127 citations), Molecular Biology (779 citations), Inorganic Chemistry (133 citations), Infectious Diseases (117 citations) and Genetics (163 citations). Joel Bard has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Andrew Bohm, Matthew H. Sazinsky, Stephen J. Lippard, Alberto Di Donato, Shui-Zhong Yan, Chester Lee Drum, Sandriyana Soelaiman, Zenon Grabarek, Yuequan Shen and Dan Lü. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.